Why India’s first US FDA-approved antibiotic can change the fight against superbugs
GS3Economy · S&T · Environment · Security· Biotechnology & health research· Prelims + Mains·
Why in news
Wockhardt received US FDA approval for ZAYNICH™, the first novel antibiotic fully discovered and commercialized by an Indian pharmaceutical company to address antimicrobial resistance.
Background
ZAYNICH™ is a novel antibiotic designed to treat complicated urinary tract infections caused by resistant Gram-negative bacteria. It was developed over 17 years at Wockhardt's research center in Chhatrapati Sambhajinagar.
Facts for Prelims
- S&TZAYNICH™: A novel antibiotic for treating resistant Gram-negative bacteria.
- FactDevelopment timeline: 17 years of research and development.
- PostUS FDA: The United States Food and Drug Administration is the regulatory body that granted approval.
- PlaceChhatrapati Sambhajinagar: Location of the research center where the drug was developed.
For Mains
Q. Discuss the significance of India's pharmaceutical R&D capabilities in addressing the global crisis of antimicrobial resistance (AMR).
Dimensions to cover in your answer
- R&D investment gap: High costs of clinical trials leading to reduced private sector interest in antibiotic discovery.
- Public health threat: Rapid emergence of multi-drug resistant (MDR) Gram-negative bacteria complicating standard infection protocols.
- Market dynamics: India's ability to provide affordable access to novel antibiotics compared to Western markets.
Keywords: Antimicrobial Resistance · Pharmaceutical R&D · Gram-negative bacteria · Public Health · Novel Chemical Entity
More Science & Technology notes
- ICEYE chooses India for sovereign SAR mission; picks Agnikul Cosmos as launch partner · 1 July 2026
- Ethanol In Petrol, E20, Supreme Court: Supreme Court Directs Status Quo On Ethanol Supply Allocation · 1 July 2026
- Maharashtra to frame guidelines for AI-powered smart glasses, set up expert panel · 30 June 2026
- India commissioned the world's first pilot hydrogen production facility powered by nuclear heat from a Fast Breeder Test Reactor at Kalpakkam · 30 June 2026
- Jagannath Nayak takes over as DG Missiles & Strategic Systems (MSS) DRDO · 30 June 2026
- The Reserve Bank of India (RBI) revised its framework for compensating victims of digital payment fraud to bolster consumer trust in the digital financial ecosystem · 30 June 2026
This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.